- Home
- ASB vs PTGX Comparison
ASB vs PTGX Comparison
Compare ASB & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASB
- PTGX
- Stock Information
- Founded
- ASB 1861
- PTGX 2006
- Country
- ASB United States
- PTGX United States
- Employees
- ASB N/A
- PTGX N/A
- Industry
- ASB Major Banks
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- ASB Finance
- PTGX Health Care
- Exchange
- ASB Nasdaq
- PTGX Nasdaq
- Market Cap
- ASB 4.4B
- PTGX 3.7B
- IPO Year
- ASB N/A
- PTGX 2016
- Fundamental
- Price
- ASB $26.25
- PTGX $58.86
- Analyst Decision
- ASB Hold
- PTGX Strong Buy
- Analyst Count
- ASB 11
- PTGX 9
- Target Price
- ASB $27.64
- PTGX $70.44
- AVG Volume (30 Days)
- ASB 1.2M
- PTGX 880.7K
- Earning Date
- ASB 10-23-2025
- PTGX 11-06-2025
- Dividend Yield
- ASB 3.50%
- PTGX N/A
- EPS Growth
- ASB N/A
- PTGX N/A
- EPS
- ASB 0.78
- PTGX 0.80
- Revenue
- ASB $1,035,964,000.00
- PTGX $209,180,000.00
- Revenue This Year
- ASB $56.79
- PTGX N/A
- Revenue Next Year
- ASB $5.69
- PTGX $185.11
- P/E Ratio
- ASB $33.50
- PTGX $73.51
- Revenue Growth
- ASB 3.82
- PTGX N/A
- 52 Week Low
- ASB $18.32
- PTGX $33.31
- 52 Week High
- ASB $28.18
- PTGX $61.89
- Technical
- Relative Strength Index (RSI)
- ASB 54.11
- PTGX 54.53
- Support Level
- ASB $25.99
- PTGX $54.50
- Resistance Level
- ASB $27.04
- PTGX $61.04
- Average True Range (ATR)
- ASB 0.48
- PTGX 2.72
- MACD
- ASB -0.06
- PTGX -0.07
- Stochastic Oscillator
- ASB 17.35
- PTGX 59.00
About ASB Associated Banc-Corp
Associated Banc-Corp is a bank holding company. The company through its subsidiaries provides a broad array of banking and nonbanking products and services to individuals and businesses. The company operates in three reportable segments; Corporate and Commercial Specialty; Community, Consumer, and Business; and Risk Management and Shared Services. The majority of its revenue is derived from the Corporate and Commercial Specialty and Community, Consumer, and Business segments.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.